<DOC>
	<DOCNO>NCT01050075</DOCNO>
	<brief_summary>RATIONALE : Acupuncture may help relieve nerve pain cause chemotherapy . PURPOSE : This randomized clinical trial study well acupuncture work treat nerve pain patient stage I , stage II , stage III breast cancer receive paclitaxel .</brief_summary>
	<brief_title>Acupuncture Treating Nerve Pain Patients With Stage I , Stage II , Stage III Breast Cancer Who Are Receiving Paclitaxel</brief_title>
	<detailed_description>PRIMARY OBJECTIVE : I . To explore potential use acupuncture prevent worsen nerve damage patient ( treatment ) due paclitaxel measure Neuropathic Pain Symptom Inventory . SECONDARY OBJECTIVES : I . Evaluate impact acupuncture base neurological assessment , quantitative sensory test nerve conduction test . II . Evaluate improvement observe treat patient peripheral neuropathy ( post-chemotherapy ) acupuncture base metric . III . To correlate objective measure neuropathy ( nerve conduction , quantitative sensory test , neuropathy composite score , blood cytokine level ) subjective questionnaire/quality life measure . OUTLINE : Patients randomize 1 2 treatment arm . ARM I : Patients receive paclitaxel every 2 week 4 course . Patients undergo acupuncture therapy comprise 2 30-minute session week 4 week course 3 4 . ARM II : Patients receive paclitaxel every 2 week 4 course . Patients undergo acupuncture therapy comprise 2 30-minute session week 4 week .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Inclusion Patients must history histologically cytologically confirm stage I , II , III breast cancer receive 2 cycle paclitaxel , expect receive paclitaxel two cycle , experience grade 1 peripheral neuropathy ( CTCAE criterion ) Performance ECOG 02 ( Karnofsky Performance Status &gt; = 60 % ) Life expectancy great 6 month Ability understand willingness sign write informed consent document Exclusion Patients radiologically confirm stage IV breast cancer Patients acupuncture previous 8 week Change use follow drug prior 4 week : opiate , antidepressant , anxiolytic ( `` change '' define initiation cessation treatment , change prescribe dose regimen ) Patients needle phobia Patients experience peripheral neuropathy prior chemotherapy Patients potential serious bleed due inherit disease hemophilia Patients diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>male breast cancer</keyword>
	<keyword>neurotoxicity</keyword>
	<keyword>recurrent breast cancer</keyword>
</DOC>